跳至主要内容
临床试验/TCTR20210715002
TCTR20210715002已完成不适用

The Pharmacokinetic Study of Conversion Tacrolimus BID to Tacrolimus OD in Kidney Transplant Patient in King Chulalongkorn Memorial Hospital.

Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University0 个研究点目标入组 20 人开始时间: 2021年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1.Post kidney transplant after 6 months or less than 10 years, 2. Mild to moderate immunological risk according to TTS (Thai Transplant Society), 3.Stable allograft function for the past 6 months by serum creatinie lesser than 3.0 mg per dL, 4. Currently on tacrolimus (BID TAC; Prograf, or OD TAC; Advagraf) no dose adjustment for 3 months

排除标准

  • 1.Pregnancy, 2.Suspicious for acute allograft rejection or history of past rejection, 3.Patient with abnormal liver function test or history of cirrhosis, 4.Patients with active infection or currentlt admission due to other medical conditions.

研究者

发起方
Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University

相似试验